Trial Profile
Phase 2a study of PXT-864 in patients with parkinson's disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Acamprosate/baclofen (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Pharnext
- 18 Feb 2016 New trial record